Mental Health in Urologic Oncology

This article is a systematic review of mental health in urologic oncology patients with prostate cancer (PCa), bladder cancer (BC), renal cell carcinoma (RCC), testicular cancer (TC), or penile cancer (PeCa). For all pathologies, a focus on increasing quality of life post-treatment demonstrated a po...

Full description

Saved in:
Bibliographic Details
Main Authors: Danyon Anderson, Abrahim N. Razzak, Matthew McDonald, David Cao, Jamal Hasoon, Omar Viswanath, Alan D. Kaye, Ivan Urits
Format: Article
Language:English
Published: Open Medical Publishing 2022-08-01
Series:Health Psychology Research
Online Access:https://doi.org/10.52965/001c.37518
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825196971015536640
author Danyon Anderson
Abrahim N. Razzak
Matthew McDonald
David Cao
Jamal Hasoon
Omar Viswanath
Alan D. Kaye
Ivan Urits
author_facet Danyon Anderson
Abrahim N. Razzak
Matthew McDonald
David Cao
Jamal Hasoon
Omar Viswanath
Alan D. Kaye
Ivan Urits
author_sort Danyon Anderson
collection DOAJ
description This article is a systematic review of mental health in urologic oncology patients with prostate cancer (PCa), bladder cancer (BC), renal cell carcinoma (RCC), testicular cancer (TC), or penile cancer (PeCa). For all pathologies, a focus on increasing quality of life post-treatment demonstrated a positive impact in reducing Mental Health Illness (MHI) prevalence. Cancer specific mental health care may be given to patients to reduce suicide risk in BC patients and sexual identify and masculinity counseling may improve mental health for TC or PeCa patients. In order to better accommodate patient’s mental health needs when undergoing GU cancer treatment, we recommend incorporation of mental health metrics such as questionnaires to assess early treatment of MHI, a greater emphasis on psychosocial support with the patient’s loved ones, peers, and healthcare team, alongside advising healthy habits such as exercise which has been shown to drastically reduce MHI incidence across all pathologies. We hope that these measures conducted by urologists and oncologists, alongside possible coordination with psychiatrists and psychologists for psychotherapy, psychopharmacology, and neuro-stimulation treatment modems may be helpful in the long term to reduce MHI incidence in urology oncology patients. Given the higher incidence of MHI in oncology patients and in the patient population after the Covid-19 pandemic, MHI awareness in the sphere of urologic oncologic treatment continues to be crucial when creating a collaborative treatment platform for patients.
format Article
id doaj-art-e003c605d9a141aaacb85ad3304b0393
institution Kabale University
issn 2420-8124
language English
publishDate 2022-08-01
publisher Open Medical Publishing
record_format Article
series Health Psychology Research
spelling doaj-art-e003c605d9a141aaacb85ad3304b03932025-02-11T20:30:31ZengOpen Medical PublishingHealth Psychology Research2420-81242022-08-01103Mental Health in Urologic OncologyDanyon AndersonAbrahim N. RazzakMatthew McDonaldDavid CaoJamal HasoonOmar ViswanathAlan D. KayeIvan UritsThis article is a systematic review of mental health in urologic oncology patients with prostate cancer (PCa), bladder cancer (BC), renal cell carcinoma (RCC), testicular cancer (TC), or penile cancer (PeCa). For all pathologies, a focus on increasing quality of life post-treatment demonstrated a positive impact in reducing Mental Health Illness (MHI) prevalence. Cancer specific mental health care may be given to patients to reduce suicide risk in BC patients and sexual identify and masculinity counseling may improve mental health for TC or PeCa patients. In order to better accommodate patient’s mental health needs when undergoing GU cancer treatment, we recommend incorporation of mental health metrics such as questionnaires to assess early treatment of MHI, a greater emphasis on psychosocial support with the patient’s loved ones, peers, and healthcare team, alongside advising healthy habits such as exercise which has been shown to drastically reduce MHI incidence across all pathologies. We hope that these measures conducted by urologists and oncologists, alongside possible coordination with psychiatrists and psychologists for psychotherapy, psychopharmacology, and neuro-stimulation treatment modems may be helpful in the long term to reduce MHI incidence in urology oncology patients. Given the higher incidence of MHI in oncology patients and in the patient population after the Covid-19 pandemic, MHI awareness in the sphere of urologic oncologic treatment continues to be crucial when creating a collaborative treatment platform for patients.https://doi.org/10.52965/001c.37518
spellingShingle Danyon Anderson
Abrahim N. Razzak
Matthew McDonald
David Cao
Jamal Hasoon
Omar Viswanath
Alan D. Kaye
Ivan Urits
Mental Health in Urologic Oncology
Health Psychology Research
title Mental Health in Urologic Oncology
title_full Mental Health in Urologic Oncology
title_fullStr Mental Health in Urologic Oncology
title_full_unstemmed Mental Health in Urologic Oncology
title_short Mental Health in Urologic Oncology
title_sort mental health in urologic oncology
url https://doi.org/10.52965/001c.37518
work_keys_str_mv AT danyonanderson mentalhealthinurologiconcology
AT abrahimnrazzak mentalhealthinurologiconcology
AT matthewmcdonald mentalhealthinurologiconcology
AT davidcao mentalhealthinurologiconcology
AT jamalhasoon mentalhealthinurologiconcology
AT omarviswanath mentalhealthinurologiconcology
AT alandkaye mentalhealthinurologiconcology
AT ivanurits mentalhealthinurologiconcology